Hemo Organic Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Friday, 29th May, 2026 at 4:00 p.m.
The primary agenda items for the board meeting include:
- Consideration and approval of the Audited Financial Results of the Company for the quarter and year ended as on 31st March, 2026
- Review of the Audit Report to be issued by the Statutory Auditor on the financial results
- Transaction of other businesses as per the agenda being circulated
The disclosure is made pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company's corporate identification number is L24231GJ1992PLC018224 and is registered at Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350.
The communication was digitally signed by Vishwambar Kameshwar Singh, Managing Director (DIN: 09822587), on 25th May, 2026 at 16:59:57 +05:30.
No financial figures, operational metrics, or specific impact assessments are disclosed in this intimation notice. The actual financial results and their implications will be determined and disclosed following the board meeting.